-
Mashup Score: 1Obesity Management - ICER - 2 year(s) ago
ICER’s analysis on the comparative clinical effectiveness and value of treatments for obesity management. Learn more.
Source: ICERCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4Understanding the utility of zero coronary calcium as a prognostic test: a Bayesian approach - PubMed - 2 year(s) ago
Understanding the utility of zero coronary calcium as a prognostic test: a Bayesian approach
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
@drjohnm https://t.co/7kyk4P3oLN
-
-
Mashup Score: 0Cost effectiveness of population screening versus no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS) - 2 year(s) ago
Rikke Søgaard, PhD, Axel Cosmus Pyndt Diederichsen, PhD, Lars M Rasmussen, DMSci, Jess Lambrechtsen, PhD, Flemming H Steffensen, PhD, Lars Frost, DMSci, PhD, Ke
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
11/14 Cost – important. Just 207 Euros! ICER analysis in EHJ - https://t.co/nbwL0Qk9PI. About 9000 Euros per QALY in all-comers, about 4000 Euros per QALY in age 65-69.
-
-
Mashup Score: 0
Original Article from The New England Journal of Medicine — Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
1/14 To facilitate discussion, I put together brief a tweetorial on the DANCAVAS trial while between sessions here in Barcelona. @NEJM link: https://t.co/U5TMN9Ngoy
-
-
Mashup Score: 0Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention - 2 year(s) ago
High-dose eicosapentaenoic acid (EPA) therapy was beneficial in high-risk patients without clinical cardiovascular disease (CVD). Whether higher plasm…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: MESA - https://t.co/e0Ca12oW1n
-
-
Mashup Score: 4
Background Lipoprotein(a) (Lp(a)) is a potent causal risk factor for cardiovascular events and mortality. However, its relationship with subclinical atherosclerosis, as defined by arterial calcification, remains unclear. This study uses the ARIC (Atherosclerosis Risk in Communities Study) to evaluat …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclero… https://t.co/zVrWKOhmAy
-
-
Mashup Score: 1Calcium Calculator - 2 year(s) ago
Input your age, select your sex and race, input (optionally) your observed coronary artery calcium (CAC) score and click “Calculate”. Last Updated: April 10, 2022 (v. 3.0) Website Created by Rehan Javaid
Source: www.cac-tools.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @aamirjavaidmed: Here is a video of our calculator https://t.co/NGuwF69q65 in action (works best on desktop). This 36-year-old Black mal…
-
-
Mashup Score: 2
CAC may be superior to the pooled cohort equations to inform the allocation of aspirin in primary prevention. Implementation of current 2019 American College of Cardiology/American Heart Association guideline recommendations together with the use of CAC for further risk assessment may result in a mo …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
@bmorecardiology @wpentz @drjohnm @CardioNerds @keaglemd @rblument1 @Cardiology Here is the paper to read. As an observational study, you will have to judge whether you are convinced by the findings. https://t.co/AXVmkTFJgp
-
-
Mashup Score: 5
An Expert Panel of the National Lipid Association reviewed the evidence related to the use of coronary artery calcium (CAC) scoring in clinical practice for adults seen for primary prevention of atherosclerotic cardiovascular disease. Recommendations for optimal use of this test in adults of various …
Source: PubMedCategories: Expert Picks, Latest HeadlinesTweet-
RT @MichaelJBlaha: @cpcannon @DrMarthaGulati @cardiojaydoc02 Explicit class 3 recommendation in new NLA guidelines: https://t.co/oGA7qBINcJ
-
@cpcannon @DrMarthaGulati @cardiojaydoc02 Explicit class 3 recommendation in new NLA guidelines: https://t.co/oGA7qBINcJ
-
-
Mashup Score: 8Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop - PubMed - 2 year(s) ago
Coronary artery calcium (CAC) is considered a useful test for enhancing risk assessment in the primary prevention setting. Clinical trials are under consideration. The National Heart, Lung, and Blood Institute convened a multidisciplinary working group on August 26 to 27, 2019, in Bethesda, Maryland …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
@drjohnm @DavidLBrownMD Real history of CAC in trials published: https://t.co/Qxj8r9ebXF. Several trials currently underway BTW. Remember CAC strategy has no pharma stakeholders. Only NHLBI to turn to, ultimately declined the VIEW trial (2012 despite fundable score). All published you can read about it.
-
RT @MichaelAlbertMD: Finally reviewed the recent ICER report on FDA-approved drugs for LT obesity treatment: https://t.co/mLuwsTz5xX Some…